Review
doi: 10.1586/14787210.6.5.601.
Current challenges in treating MRSA: what are the options?
Affiliations
- PMID: 18847401
- DOI: 10.1586/14787210.6.5.601
Item in Clipboard
Review
Current challenges in treating MRSA: what are the options?
Expert Rev Anti Infect Ther.
2008 Oct.
Abstract
This review looks at the challenges facing the worldwide community with the increasing problem of methicillin resistance in Staphylococcus aureus. The epidemiology and natural history of community-associated methicillin-resistant Staphylococcus aureus and the challenge of control is discussed. Options for treatment and review of key antimicrobial agents acting against methicillin-resistant S. aureus, both currently in use and in development, are addressed. There are a number of new agents, the place of which in therapeutic regimens is yet to emerge. The review attempts to inform the reader of the probable position of these agents.
Similar articles
-
The evolution of Staphylococcus aureus.Infect Genet Evol. 2008 Dec;8(6):747-63. doi: 10.1016/j.meegid.2008.07.007. Epub 2008 Jul 29. Infect Genet Evol. 2008. PMID: 18718557 Review.
-
Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.Int J Antimicrob Agents. 2009 Aug;34(2):148-55. doi: 10.1016/j.ijantimicag.2009.03.004. Epub 2009 Apr 25. Int J Antimicrob Agents. 2009. PMID: 19394801
-
Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis.J Antimicrob Chemother. 2008 Jan;61(1):1-7. doi: 10.1093/jac/dkm410. Epub 2007 Oct 25. J Antimicrob Chemother. 2008. PMID: 17962214
-
Pulmonary infections and community associated methicillin resistant Staphylococcus aureus: a dangerous mix?Paediatr Respir Rev. 2011 Sep;12(3):182-9. doi: 10.1016/j.prrv.2010.10.007. Epub 2010 Nov 20. Paediatr Respir Rev. 2011. PMID: 21722847 Review.
-
Community-acquired methicillin-resistant Staphylococcus aureus--a review of literature.Afr J Med Med Sci. 2011 Jun;40(2):97-107. Afr J Med Med Sci. 2011. PMID: 22195376 Review.
Cited by
-
Activity of tedizolid (TR-700) against well-characterized methicillin-resistant Staphylococcus aureus strains of diverse epidemiological origins.Antimicrob Agents Chemother. 2013 Jun;57(6):2892-5. doi: 10.1128/AAC.00274-13. Epub 2013 Apr 9. Antimicrob Agents Chemother. 2013. PMID: 23571550 Free PMC article.
-
Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio.Antimicrob Agents Chemother. 2011 Apr;55(4):1684-92. doi: 10.1128/AAC.01308-10. Epub 2011 Jan 24. Antimicrob Agents Chemother. 2011. PMID: 21263048 Free PMC article.
-
In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.Antimicrob Agents Chemother. 2011 Jun;55(6):2860-71. doi: 10.1128/AAC.01666-10. Epub 2011 Apr 4. Antimicrob Agents Chemother. 2011. PMID: 21464250 Free PMC article.
-
Human Milk-Derived Enterococcus faecalis HM20: A Potential Alternative Agent of Antimicrobial Effect against Methicillin-Resistant Staphylococcus aureus (MRSA).Microorganisms. 2024 Jan 31;12(2):306. doi: 10.3390/microorganisms12020306. Microorganisms. 2024. PMID: 38399710 Free PMC article.
-
Recurrent Challenges for Clinicians: Emergence of Methicillin-Resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options.J Lab Physicians. 2013 Jul;5(2):71-8. doi: 10.4103/0974-2727.119843. J Lab Physicians. 2013. PMID: 24701097 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
